End-of-day quote
Nyse
|
5-day change
|
1st Jan Change
|
- USD
|
-.--%
|
|
-.--%
|
-.--%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
2,345
|
1,944
|
1,403
|
1,154
|
1,134
|
1,133
|
-
|
-
|
Enterprise Value (EV)
1 |
4,179
|
3,209
|
2,144
|
1,918
|
1,914
|
1,825
|
1,726
|
1,613
|
P/E ratio
|
29.1
x
|
-11
x
|
1,024
x
|
17
x
|
16.3
x
|
12.2
x
|
9.49
x
|
8
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.5
x
|
1.76
x
|
2.3
x
|
1.41
x
|
1.64
x
|
1.54
x
|
1.45
x
|
1.39
x
|
EV / Revenue
|
2.67
x
|
2.9
x
|
3.51
x
|
2.34
x
|
2.77
x
|
2.48
x
|
2.21
x
|
1.97
x
|
EV / EBITDA
|
8.81
x
|
9.49
x
|
9.42
x
|
6.93
x
|
7.36
x
|
6.91
x
|
5.83
x
|
4.99
x
|
EV / FCF
|
29.8
x
|
25.4
x
|
30.7
x
|
15
x
|
26.5
x
|
17.4
x
|
10.9
x
|
9.32
x
|
FCF Yield
|
3.35%
|
3.94%
|
3.26%
|
6.66%
|
3.78%
|
5.75%
|
9.21%
|
10.7%
|
Price to Book
|
1.32
x
|
1.52
x
|
1.89
x
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
136,474
|
136,338
|
137,060
|
130,253
|
116,117
|
117,005
|
-
|
-
|
Reference price
2 |
17.18
|
14.26
|
10.24
|
8.860
|
9.770
|
9.830
|
9.830
|
9.830
|
Announcement Date
|
20/02/20
|
09/03/21
|
25/02/22
|
28/02/23
|
28/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
1,567
|
1,107
|
611.2
|
820.2
|
691.1
|
735.9
|
779.1
|
816.7
|
EBITDA
1 |
474.3
|
338
|
227.6
|
276.8
|
259.9
|
264.1
|
296.1
|
323.1
|
EBIT
1 |
292.2
|
186.2
|
147.9
|
197.6
|
175.3
|
171.8
|
209.1
|
245
|
Operating Margin
|
18.65%
|
16.81%
|
24.2%
|
24.09%
|
25.37%
|
23.35%
|
26.84%
|
30%
|
Earnings before Tax (EBT)
1 |
121
|
-227.6
|
-
|
94.7
|
82
|
123
|
162
|
-
|
Net income
1 |
79.5
|
-176.3
|
1.8
|
73.7
|
71.2
|
93
|
123
|
-
|
Net margin
|
5.07%
|
-15.92%
|
0.29%
|
8.99%
|
10.3%
|
12.64%
|
15.79%
|
-
|
EPS
2 |
0.5900
|
-1.300
|
0.0100
|
0.5200
|
0.6000
|
0.8057
|
1.036
|
1.229
|
Free Cash Flow
1 |
140.1
|
126.5
|
69.9
|
127.7
|
72.3
|
105
|
159
|
173
|
FCF margin
|
8.94%
|
11.42%
|
11.44%
|
15.57%
|
10.46%
|
14.27%
|
20.41%
|
21.18%
|
FCF Conversion (EBITDA)
|
29.54%
|
37.43%
|
30.71%
|
46.13%
|
27.82%
|
39.75%
|
53.69%
|
53.54%
|
FCF Conversion (Net income)
|
176.25%
|
-
|
3,883.33%
|
173.27%
|
101.54%
|
112.9%
|
129.27%
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
20/02/20
|
09/03/21
|
25/02/22
|
28/02/23
|
28/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
170.2
|
179.7
|
225.2
|
232.5
|
182.8
|
160.9
|
184.1
|
173.3
|
172.8
|
160.5
|
184
|
197.5
|
194.8
|
169
|
204
|
EBITDA
1 |
63.2
|
59.2
|
72.9
|
75.4
|
69.2
|
42.9
|
79.3
|
67.9
|
69.8
|
45.5
|
54.92
|
80.02
|
83.96
|
55
|
77
|
EBIT
1 |
43.6
|
39.7
|
53.2
|
55.8
|
48.8
|
22.7
|
58.3
|
46.6
|
47.7
|
23.6
|
31.97
|
56.02
|
56.9
|
-
|
-
|
Operating Margin
|
25.62%
|
22.09%
|
23.62%
|
24%
|
26.7%
|
14.11%
|
31.67%
|
26.89%
|
27.6%
|
14.7%
|
17.38%
|
28.36%
|
29.21%
|
-
|
-
|
Earnings before Tax (EBT)
1 |
14.8
|
13.6
|
26.5
|
30.3
|
24.4
|
-0.6
|
34.9
|
24.5
|
23.2
|
2.4
|
20
|
46
|
50
|
-
|
-
|
Net income
1 |
7.8
|
7.9
|
19.2
|
21.3
|
25.4
|
-1.5
|
26.1
|
16.6
|
30
|
1.2
|
15
|
35
|
38
|
-
|
-
|
Net margin
|
4.58%
|
4.4%
|
8.53%
|
9.16%
|
13.89%
|
-0.93%
|
14.18%
|
9.58%
|
17.36%
|
0.75%
|
8.15%
|
17.72%
|
19.5%
|
-
|
-
|
EPS
2 |
0.0600
|
0.0600
|
0.1400
|
0.1600
|
0.1700
|
-0.0100
|
0.2200
|
0.1400
|
0.2600
|
0.0100
|
0.1072
|
0.2876
|
0.3044
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
25/02/22
|
28/04/22
|
29/07/22
|
01/11/22
|
28/02/23
|
04/05/23
|
03/08/23
|
02/11/23
|
28/02/24
|
02/05/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
1,835
|
1,265
|
741
|
764
|
780
|
692
|
593
|
480
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
3.868
x
|
3.742
x
|
3.255
x
|
2.76
x
|
2.999
x
|
2.62
x
|
2.002
x
|
1.485
x
|
Free Cash Flow
1 |
140
|
127
|
69.9
|
128
|
72.3
|
105
|
159
|
173
|
ROE (net income / shareholders' equity)
|
7.28%
|
8.96%
|
6.9%
|
15.6%
|
12.7%
|
13.6%
|
16.4%
|
17%
|
ROA (Net income/ Total Assets)
|
2.9%
|
3.64%
|
2.71%
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
2,746
|
-4,842
|
66.33
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
13.00
|
9.370
|
5.410
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
2 |
1.980
|
1.650
|
0.9600
|
-
|
0.5400
|
1.200
|
1.750
|
1.050
|
Capex
1 |
128
|
97.1
|
60
|
58.9
|
65.3
|
78
|
75.5
|
75.5
|
Capex / Sales
|
8.15%
|
8.77%
|
9.82%
|
7.18%
|
9.45%
|
10.6%
|
9.69%
|
9.24%
|
Announcement Date
|
20/02/20
|
09/03/21
|
25/02/22
|
28/02/23
|
28/02/24
|
-
|
-
|
-
|
Last Close Price
9.83
USD Average target price
13.86
USD Spread / Average Target +40.97% Consensus |
1st Jan change
|
Capi.
|
---|
| -1.30% | 76.24B | | +0.19% | 47.61B | | +3.87% | 32.43B | | +10.01% | 18.39B | | +11.76% | 11.77B | | -16.29% | 10.95B | | +1.70% | 10.94B | | -0.10% | 9.21B | | -8.07% | 8.06B |
Diversified Chemicals
|